Access cutting-edge chronic myeloid leukemia treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access chronic myeloid leukemia specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic myeloid leukemia treatment provided free
The aim of this study is to support development of asciminib in the pediatric population (1 to \<18 years) previously treated with one or more TKIs. Full extrapolation of the efficacy of asciminib from adult to pediatric patients will be conducted. Full extrapolation is based on the concept that CML in the pediatric population has the same pathogenesis, similar clinical characteristics and progression pattern as in adults.
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this chronic myeloid leukemia clinical trial in New York, NY
If you're searching for chronic myeloid leukemia treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic myeloid leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.